These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 32168839)

  • 1.
    Jemel S; Guillot J; Kallel K; Botterel F; Dannaoui E
    Microorganisms; 2020 Mar; 8(3):. PubMed ID: 32168839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment.
    Maurer E; Hörtnagl C; Lackner M; Grässle D; Naschberger V; Moser P; Segal E; Semis M; Lass-Flörl C; Binder U
    Med Mycol; 2019 Apr; 57(3):351-362. PubMed ID: 29924357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast.
    Mesa-Arango AC; Forastiero A; Bernal-Martínez L; Cuenca-Estrella M; Mellado E; Zaragoza O
    Med Mycol; 2013 Jul; 51(5):461-72. PubMed ID: 23170962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virulence of Candida haemulonii complex in Galleria mellonella and efficacy of classical antifungal drugs: a comparative study with other clinically relevant non-albicans Candida species.
    Silva LN; Campos-Silva R; Ramos LS; Trentin DS; Macedo AJ; Branquinha MH; Santos ALS
    FEMS Yeast Res; 2018 Nov; 18(7):. PubMed ID: 30052907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galleria mellonella: An invertebrate model to study pathogenicity in correctly defined fungal species.
    Binder U; Maurer E; Lass-Flörl C
    Fungal Biol; 2016 Feb; 120(2):288-95. PubMed ID: 26781383
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Curtis A; Binder U; Kavanagh K
    Front Fungal Biol; 2022; 3():893494. PubMed ID: 37746216
    [No Abstract]   [Full Text] [Related]  

  • 7. The Use of Galleria mellonella Larvae to Study the Pathogenicity and Clonal Lineage-Specific Behaviors of the Emerging Fungal Pathogen Candida auris.
    Borman AM
    Methods Mol Biol; 2022; 2517():287-298. PubMed ID: 35674963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal Activity, Toxicity, and Membranolytic Action of a Mastoparan Analog Peptide.
    Singulani JL; Galeane MC; Ramos MD; Gomes PC; Dos Santos CT; de Souza BM; Palma MS; Fusco Almeida AM; Mendes Giannini MJS
    Front Cell Infect Microbiol; 2019; 9():419. PubMed ID: 31867293
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Giammarino A; Bellucci N; Angiolella L
    Pathogens; 2024 Mar; 13(3):. PubMed ID: 38535576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alternative host model of a mixed fungal infection by azole susceptible and resistant Aspergillus spp strains.
    Alcazar-Fuoli L; Buitrago M; Gomez-Lopez A; Mellado E
    Virulence; 2015; 6(4):376-84. PubMed ID: 26065322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
    Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
    Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of
    Kavanagh K; Sheehan G
    J Fungi (Basel); 2018 Sep; 4(3):. PubMed ID: 30235800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive bioluminescence imaging of cryptococcosis in
    Vanhoffelen E; Vermoesen L; Michiels L; Lagrou K; Reséndiz-Sharpe A; Vande Velde G
    Virulence; 2024 Dec; 15(1):2327883. PubMed ID: 38465639
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the efficacy of antifungal drugs against Paracoccidioides brasiliensis and Paracoccidioides lutzii in a Galleria mellonella model.
    de Lacorte Singulani J; Scorzoni L; de Paula E Silva AC; Fusco-Almeida AM; Mendes-Giannini MJ
    Int J Antimicrob Agents; 2016 Sep; 48(3):292-7. PubMed ID: 27444116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing Pilocarpine Hydrochloride for Treatment of Candida albicans Infections.
    Nile C; Falleni M; Cirasola D; Alghamdi A; Anderson OF; Delaney C; Ramage G; Ottaviano E; Tosi D; Bulfamante G; Morace G; Borghi E
    mSphere; 2019 Jan; 4(1):. PubMed ID: 30674648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of voriconazole in vitro and in invertebrate model of cryptococcosis.
    de Castro Spadari C; da Silva de Bastiani FWM; Pisani PBB; de Azevedo Melo AS; Ishida K
    Arch Microbiol; 2020 May; 202(4):773-784. PubMed ID: 31832690
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Stempinski PR; Smith DFQ; Casadevall A
    Bio Protoc; 2022 Aug; 12(15):. PubMed ID: 36082366
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo activity of fluconazole/tetracycline combinations in Galleria mellonella with resistant Candida albicans infection.
    Gu W; Yu Q; Yu C; Sun S
    J Glob Antimicrob Resist; 2018 Jun; 13():74-80. PubMed ID: 29191612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UtilisingGalleria mellonella larvae for studying in vivo activity of conventional and novel antimicrobial agents.
    Piatek M; Sheehan G; Kavanagh K
    Pathog Dis; 2020 Nov; 78(8):. PubMed ID: 33016311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis.
    Mylonakis E; Moreno R; El Khoury JB; Idnurm A; Heitman J; Calderwood SB; Ausubel FM; Diener A
    Infect Immun; 2005 Jul; 73(7):3842-50. PubMed ID: 15972469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.